Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

The Ministry of Health has conceded a shortage of vaccines for newborns. The Director General for Health Patrick Amoth on ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Through the Kenya Medical Supplies Authority (KEMSA) Chief Executive Officer Waqo Erjesa, the government confirmed that there ...

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

The country has run out of essential medical supplies, precipitating a serious national public healthcare crisis. The lack of HIV medication, condoms and baby vaccines is endangering millions of lives ...

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

Kenya has completely run out of essential medical supplies—including HIV medicines, testing kits, and vaccines—putting ...

The country’s public and private hospitals are facing severe shortages of Atazanavir, a crucial HIV drug, as well as condoms, ...

Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...